Does Light Traveling Through Space Wear Out?
My telescope, set up for astrophotography in my light-polluted San Diego backyard, was pointed at a galaxy unfathomably far from Earth. My wife, Cristina, walked up just as the first space photo streamed to my tablet. It sparkled on the screen in front of us.
'That's the Pinwheel galaxy,' I said. The name is derived from its shape–albeit this pinwheel contains about a trillion stars.
The light from the Pinwheel traveled for 25 million years across the universe–about 150 quintillion miles–to get to my telescope.
My wife wondered: 'Doesn't light get tired during such a long journey?'
Her curiosity triggered a thought-provoking conversation about light. Ultimately, why doesn't light wear out and lose energy over time?
Let's talk about light
I am an astrophysicist, and one of the first things I learned in my studies is how light often behaves in ways that defy our intuitions. Light is electromagnetic radiation: basically, an electric wave and a magnetic wave coupled together and traveling through space-time. It has no mass. That point is critical because the mass of an object, whether a speck of dust or a spaceship, limits the top speed it can travel through space.
But because light is massless, it's able to reach the maximum speed limit in a vacuum–about 186,000 miles (300,000 kilometers) per second, or almost 6 trillion miles per year (9.6 trillion kilometers). Nothing traveling through space is faster. To put that into perspective: In the time it takes you to blink your eyes, a particle of light travels around the circumference of the Earth more than twice.
As incredibly fast as that is, space is incredibly spread out. Light from the Sun, which is 93 million miles (about 150 million kilometers) from Earth, takes just over eight minutes to reach us. In other words, the sunlight you see is eight minutes old. Alpha Centauri, the nearest star to us after the Sun, is 26 trillion miles away (about 41 trillion kilometers). So by the time you see it in the night sky, its light is just over four years old. Or, as astronomers say, it's four light years away.
With those enormous distances in mind, consider Cristina's question: How can light travel across the universe and not slowly lose energy?
Actually, some light does lose energy. This happens when it bounces off something, such as interstellar dust, and is scattered about. But most light just goes and goes, without colliding with anything. This is almost always the case because space is mostly empty–nothingness. So there's nothing in the way. When light travels unimpeded, it loses no energy. It can maintain that 186,000-mile-per-second speed forever.
It's about time
Here's another concept: Picture yourself as an astronaut on board the International Space Station. You're orbiting at 17,000 miles (about 27,000 kilometers) per hour. Compared with someone on Earth, your wristwatch will tick 0.01 seconds slower over one year.
That's an example of time dilation–time moving at different speeds under different conditions. If you're moving really fast, or close to a large gravitational field, your clock will tick more slowly than someone moving slower than you, or who is further from a large gravitational field. To say it succinctly, time is relative.
Now consider that light is inextricably connected to time. Picture sitting on a photon, a fundamental particle of light; here, you'd experience maximum time dilation. Everyone on Earth would clock you at the speed of light, but from your reference frame, time would completely stop.
That's because the 'clocks' measuring time are in two different places going vastly different speeds: the photon moving at the speed of light, and the comparatively slowpoke speed of Earth going around the Sun.
What's more, when you're traveling at or close to the speed of light, the distance between where you are and where you're going gets shorter. That is, space itself becomes more compact in the direction of motion–so the faster you can go, the shorter your journey has to be. In other words, for the photon, space gets squished.
Which brings us back to my picture of the Pinwheel galaxy. From the photon's perspective, a star within the galaxy emitted it, and then a single pixel in my backyard camera absorbed it, at exactly the same time. Because space is squished, to the photon the journey was infinitely fast and infinitely short, a tiny fraction of a second.
But from our perspective on Earth, the photon left the galaxy 25 million years ago and traveled 25 million light years across space until it landed on my tablet in my backyard.
And there, on a cool spring night, its stunning image inspired a delightful conversation between a nerdy scientist and his curious wife.
Jarred Roberts, Project Scientist, University of California, San Diego. This article is republished from The Conversation under a Creative Commons license. Read the original article.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Top Updates in 2025 ACS Management Guidelines
The 2025 American Heart Association/American College of Cardiology Guidelines on the management of acute coronary syndromes (ACS) were finally published recently, marking the first update after an 11-year hiatus. Despite this long gap, most acute care clinicians have remained current on ACS management through the European guidelines and other continuing medical education sources. Still, many of us have been eager to see whether the new US guidelines would contain any surprises or major breakthroughs. For those that have kept up with the literature on accelerated diagnostic protocols, troponins, anticoagulants, and related topics, the new guidelines may not feel groundbreaking. Nonetheless, the publication provided some critical reminders and a few key updates that all acute care providers should know. What follows is a selection of the most important takeaways, in my opinion, for providing acute care to patients presenting with ACS. This is not intended to be a comprehensive review of ACS management or of concepts that are already well-established in current practice. Key Points and Updated Information Posterior MI remains underdiagnosed. Missed or delayed diagnosis of acute posterior myocardial infarction (MI) remains common in acute care, largely because ST-segment elevation (STE) is lacking on the standard 12-lead ECG. Instead, these patients tend to present with ST-segment depression in the right precordial leads V1-V3. The authors remind us that the recommended method of detecting posterior MI is through the use of posterior leads in any patients with concerning symptoms and ST-depression in the right precordial leads. If ≥ 0.5 mm of STE is present in any one of the posterior leads, the diagnosis of acute posterior MI is made and justifies acute reperfusion therapy (ie, thrombolytics or immediate cardiac catheterization/percutaneous coronary intervention). Missed or delayed diagnosis of acute posterior myocardial infarction (MI) remains common in acute care, largely because ST-segment elevation (STE) is lacking on the standard 12-lead ECG. Instead, these patients tend to present with ST-segment depression in the right precordial leads V1-V3. The authors remind us that the recommended method of detecting posterior MI is through the use of posterior leads in any patients with concerning symptoms and ST-depression in the right precordial leads. If ≥ 0.5 mm of STE is present in any one of the posterior leads, the diagnosis of acute posterior MI is made and justifies acute reperfusion therapy (ie, thrombolytics or immediate cardiac catheterization/percutaneous coronary intervention). A normal ECG does not rule out ACS. The authors also remind us that the absence of electrocardiographic findings of ischemia does not rule out ACS. The authors also remind us that the absence of electrocardiographic findings of ischemia does not rule out ACS. Troponin-negative ACS ('unstable angina') still exists. The authors spend some time reviewing the pathophysiology of ACS and its correlation with troponin elevation. In this section, they remind us of a critical point: 'Unstable angina' (ie, troponin-negative ACS) still exists, even in this day of highly sensitive troponins. Just as they have reminded us that a nonischemic ECG does not rule out ACS, a negative troponin does not rule out ACS. They also remind us that even in the setting of a STEMI, a troponin test may be negative if measured within a short time from the onset of symptoms. The authors spend some time reviewing the pathophysiology of ACS and its correlation with troponin elevation. In this section, they remind us of a critical point: 'Unstable angina' (ie, troponin-negative ACS) still exists, even in this day of highly sensitive troponins. Just as they have reminded us that a nonischemic ECG does not rule out ACS, a negative troponin does not rule out ACS. They also remind us that even in the setting of a STEMI, a troponin test may be negative if measured within a short time from the onset of symptoms. Repeat ECGs are essential. The importance of serial ECG testing in patients with concerning symptoms and initially negative ECGs is emphasized. The authors state that 11% of patients ultimately diagnosed with STEMI had an initial ECG that was negative. Therefore, failure to repeat ECGs in this group of patients can result in a significant number of missed STEMIs and, in my experience, has been a common complaint in litigated cases. The importance of serial ECG testing in patients with concerning symptoms and initially negative ECGs is emphasized. The authors state that 11% of patients ultimately diagnosed with STEMI had an initial ECG that was negative. Therefore, failure to repeat ECGs in this group of patients can result in a significant number of missed STEMIs and, in my experience, has been a common complaint in litigated cases. Some patients require urgent catheterization despite the absence of STE. Another common cause of litigation is failure of healthcare providers to remember that there are groups of patients that need immediate cardiac catheterization despite the absence of STE on the ECG. In fact, the guideline indicates that catheterization should be undergone within 2 hours (Class I recommendation). These patients with ACS are categorized as unstable or very high-risk, and they include: Patients in cardiogenic shock. Patients with signs or symptoms of acute heart failure, including new or worsening mitral regurgitation or acute pulmonary edema. Patients with refractory angina. Patients with hemodynamic or electrical instability (eg, sustained ventricular tachycardia or ventricular fibrillation). Another common cause of litigation is failure of healthcare providers to remember that there are groups of patients that need immediate cardiac catheterization despite the absence of STE on the ECG. In fact, the guideline indicates that catheterization should be undergone within 2 hours (Class I recommendation). These patients with ACS are categorized as unstable or very high-risk, and they include: Blood transfusion thresholds remain uncertain. The indication for blood transfusion in patients with ACS has been a source of uncertainty for decades. Although large randomized studies to provide a clear answer are still lacking, the authors suggest (Class IIb) that in patients with ACS and acute or chronic anemia, packed cell transfusions should be provided to achieve a hemoglobin level ≥ 10 g/dL in order to reduce cardiovascular events. Viewpoint The ability to manage ACS in an evidence-based manner is critical to anyone who practices acute care medicine. These most recent US guidelines provide a fairly comprehensive review of the management of ACS, and I recommend a thorough read of the entire publication. However, I would most strongly emphasize knowledge of the points noted above because, in my experience, these have continued to be a source of confusion or missed opportunities to diagnose and properly manage this high-risk group of patients. Amal Mattu, MD, is a professor, vice chair of education, and co-director of the emergency cardiology fellowship in the Department of Emergency Medicine at the University of Maryland School of Medicine in Baltimore. Follow Dr Mattu on X.
Wall Street Journal
an hour ago
- Wall Street Journal
Google Signs Deal to Buy Fusion Energy From Bill Gates-Backed Nuclear Startup
Google signed one of the world's first commercial deals for fusion energy, in an agreement with nuclear startup Commonwealth Fusion Systems. It is a bet on future technology. Nuclear fusion—the process that fuels the stars—has never been used for commercial energy production. CFS, which is backed by Bill Gates's technology fund Breakthrough Energy Ventures, is aiming to start producing commercial fusion energy in the 2030s.
Fast Company
an hour ago
- Fast Company
New MIT tech turns desert air into safe drinking water
An innovative and potentially impactful new device can turn air into drinkable water, even in the driest climates. The tool, which comes from researchers at MIT, could be a huge step towards making safe drinking water worldwide a reality. Lack thereof impacts 2.2 billion people, per a study on the invention, which was recently published in journal Nature Water. The device was developed by Professor Xuanhe Zhao, the Uncas and Helen Whitaker Professor of Mechanical Engineering and Civil and Environmental Engineering at MIT, and his colleagues. According to the study, the contraption is made from hydrogel, a material that absorbs water, and lithium salts that can store water molecules. The substance is enclosed between two layers of glass, and at night, pulls water vapor from the atmosphere. During the day, the water condenses and drips into tubes. It's is about the size of a standard window, but even in environments that are hot and dry, it's able to capture water. Zhao's team tested the tool in the driest environment in the U.S. — Death Valley, California. Even in the ultra-dry conditions, the tool was able to capture 160 milliliters per day (about two-thirds of a cup). The success of the model has the scientists thinking on a bigger scale. 'We have built a meter-scale device that we hope to deploy in resource-limited regions, where even a solar cell is not very accessible,' says Xuanhe Zhao, per MIT News. Zhao continued, 'It's a test of feasibility in scaling up this water harvesting technology. Now people can build it even larger, or make it into parallel panels, to supply drinking water to people and achieve real impact.' The new design addresses several issues that past similar devices have come up against. It's better at absorbing water than metal-organic frameworks (MOFs) that can also capture water from air. The new design, which has a sophisticated composition and added materials, is also better at limiting salt leakage. During the experiment, that meant that the water collected met criteria for safe drinking water. 'We imagine that you could one day deploy an array of these panels, and the footprint is very small because they are all vertical,' says Zhao. 'Then you could have many panels together, collecting water all the time, at household scale.'
